These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11472421)

  • 1. Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis.
    Hashimoto Y; Matsuoka N; Kawakami A; Tsuboi M; Nakashima T; Eguchi K; Tomioka T; Kanematsu T
    Clin Exp Immunol; 2001 Jul; 125(1):19-24. PubMed ID: 11472421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL.
    Migita K; Origuchi T; Kawabe Y; Tominaga M; Ida H; Kawakami A; Eguchi K
    Transplantation; 1999 Oct; 68(7):1018-23. PubMed ID: 10532544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of the TCR-CD3 complex with CD4, CD8 or LFA-1 induces an anti-apoptotic signal in thymocytes: the signal is canceled by FK506.
    Zhao Y; Iwata M
    Int Immunol; 1995 Sep; 7(9):1387-96. PubMed ID: 7495746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 potentiates steroid-induced T-cell apoptosis.
    Migita K; Eguchi K; Kawabe Y; Origuchi T; Tominaga M; Nagataki S
    Transplantation; 1997 Nov; 64(9):1365-9. PubMed ID: 9371682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (tacrolimus)1.
    Almawi WY; Assi JW; Chudzik DM; Jaoude MM; Rieder MJ
    Cell Transplant; 2001; 10(7):615-23. PubMed ID: 11714196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages.
    Hortelano S; López-Collazo E; Boscá L
    Br J Pharmacol; 1999 Mar; 126(5):1139-46. PubMed ID: 10205001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506.
    Brunner T; Yoo NJ; LaFace D; Ware CF; Green DR
    Int Immunol; 1996 Jul; 8(7):1017-26. PubMed ID: 8757947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
    Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
    Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
    Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
    Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus-induced apoptotic signal transduction pathway.
    Choi SJ; You HS; Chung SY
    Transplant Proc; 2008 Oct; 40(8):2734-6. PubMed ID: 18929848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis.
    Mayer JM; Laine VJ; Gezgin A; Kolodziej S; Nevalainen TJ; Storck M; Beger HG
    Eur J Surg; 2000 Sep; 166(9):734-41. PubMed ID: 11034471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin activation protects T cells from glucocorticoid-induced apoptosis.
    Zhao Y; Tozawa Y; Iseki R; Mukai M; Iwata M
    J Immunol; 1995 Jun; 154(12):6346-54. PubMed ID: 7539018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation.
    Miyamoto S; Safer B
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):803-12. PubMed ID: 10585867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells.
    Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.
    Sawada S; Suzuki G; Kawase Y; Takaku F
    J Immunol; 1987 Sep; 139(6):1797-803. PubMed ID: 2442255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.
    Imado T; Iwasaki T; Kuroiwa T; Sano H; Hara H
    Transplantation; 2004 Feb; 77(3):391-8. PubMed ID: 14966413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tacrolimus derivatives on immunosuppression.
    Choi D; Cho H
    Arch Pharm Res; 2009 Apr; 32(4):549-57. PubMed ID: 19407973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo.
    Orange DE; Blachere NE; Fak J; Parveen S; Frank MO; Herre M; Tian S; Monette S; Darnell RB
    Elife; 2013 Feb; 2():e00105. PubMed ID: 23390586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.